UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~January~~March 14, 2015

LANTHEUS MEDICAL IMAGING, INC.

(Exact name of registrant as specified in its charter)

Delaware

333-169785

51-0396366

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

331 Treble Cove Road, North Billerica, MA 01862

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: (978) 671-8001

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 82.0102. ~~Other~~Results ~~Events~~of Operations and Financial Condition.

~~The~~On ~~Company’s~~March 4, ~~written~~2015, ~~supply~~Lantheus ~~agreements~~Medical ~~with~~Imaging, ~~Cardinal~~Inc. (the ~~Health~~“Company”) ~~relating~~announced tovia ~~TechneLite generators,~~press ~~Xenon,~~release ~~Neurolite,~~its ~~Cardiolite~~financial ~~and~~results ~~certain~~as ~~other~~of ~~products~~and ~~expired~~for inthe ~~accordance~~three ~~with~~and ~~their~~twelve ~~terms~~months onended December 31, 2014. A copy of that press release is being furnished as Exhibit 99.1 and is hereby incorporated by reference.

~~Following~~The ~~extended discussions~~information ~~with~~furnished ~~Cardinal~~pursuant ~~Health~~to ~~that~~this ~~have~~Item 2.02, ~~not~~including ~~resulted~~Exhibit ~~in a new set of written supply agreements~~99.1, ~~the~~shall ~~Company~~not ~~has~~be ~~entered~~deemed ~~2015~~“filed” ~~without~~for ~~written~~purposes ~~supply~~of Section 18 ~~agreements. In the absence~~ of ~~written supply agreements,~~ the ~~Company~~Securities ~~will~~Exchange ~~continue~~Act toof ~~offer all products to Cardinal Health~~1934, atas ~~substantially~~amended ~~higher prices. The Company cannot predict~~ (the ~~volumes~~“Exchange Act”), or ~~product~~otherwise ~~mix~~subject ~~Cardinal Health will continue~~ to ~~order and purchase, and such volumes and product mix may vary over time. In~~ the ~~absence~~liabilities ofunder ~~written supply agreements with Cardinal Health, the Company believes it is likely~~ that ~~future~~Section ~~unit~~and ~~sales~~shall ~~volumes~~not ~~will~~be ~~decrease~~deemed ~~from levels experienced throughout 2014. The Company also currently believes that the operating profit contribution from sales~~ to ~~Cardinal~~ ~~Health in 2015 will~~ be ~~generally~~incorporated ~~consistent~~by ~~with~~reference ~~2014~~into ~~levels~~any ~~due~~filing ~~to substantially higher pricing for all products. However, ultimate future levels~~ of ~~net~~the ~~revenue and operating profit associated with Cardinal Health cannot be predicted at~~Company ~~this~~under ~~time~~the ~~because~~Securities ~~such~~Act ~~amounts~~of ~~depend~~1933, onas ~~future unit sales volumes~~amended, ~~product~~or ~~mix~~the ~~and~~Exchange ~~pricing to Cardinal Health~~Act.

ToItem assure continued availability of all the Company’s products for patients and health care practitioners, the Company will continue to make available to Cardinal Health all of the Company’s products without written supply agreements in effect, whether or not the parties eventually reach agreement on mutually-acceptable terms to new written supply agreements9.01. ~~The~~Financial ~~Company~~Statements ~~can give no assurance that such supply agreements will ultimately be finalized~~ and ~~executed~~Exhibits.

~~Safe~~(d) ~~Harbor~~Exhibits ~~for Forward-Looking and Cautionary Statements~~

This current report contains forward-looking statements. Forward-looking statements are based on our current expectations and assumptions regarding our business and other future conditions. Such forward-looking statements are subject to risks and uncertainties that may be described from time to time in the Company’s filings with the Securities and Exchange Commission. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. The matters referred to in the forward-looking statements contained in this current report may not in fact occur. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.


Exhibit No.		Description

99.1*		Press release of Lantheus Medical Imaging, Inc. dated March 4, 2015, announcing its financial results as of and for the three and twelve months ended December 31, 2014.

Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LANTHEUS MEDICAL IMAGING, INC. By: /s/ Michael P. Duffy Name: ~~Title:~~ Michael P. Duffy Title: Vice President and General Counsel

Date: ~~January~~March 64, 2015

EXHIBIT INDEX


Exhibit No.		Description

99.1*		Press release of Lantheus Medical Imaging, Inc. dated March 4, 2015, announcing its financial results as of and for the three and twelve months ended December 31, 2014.

Filing Compare · Lantheus Medical Imaging, Inc.